Exencial Wealth Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.74M | Sell |
38,212
-3,212
| -8% | -$247K | 0.09% | 195 |
|
|
2025
Q4 | $3.29M | Sell |
41,424
-3,688
| -8% | -$291K | 0.1% | 176 |
|
|
2025
Q3 | $3.4M | Buy |
45,112
+2,050
| +5% | +$140K | 0.11% | 165 |
|
|
2025
Q2 | $2.97M | Sell |
43,062
-1,742
| -4% | -$114K | 0.1% | 179 |
|
|
2025
Q1 | $3.04M | Buy |
44,804
+575
| +1% | +$34.4K | 0.11% | 176 |
|
|
2024
Q4 | $1.99M | Sell |
44,229
-2,207
| -5% | -$124K | 0.07% | 210 |
|
|
2024
Q3 | $2.92M | Sell |
46,436
-1,570
| -3% | -$91.6K | 0.1% | 176 |
|
|
2024
Q2 | $2.84M | Sell |
48,006
-8,453
| -15% | -$529K | 0.11% | 177 |
|
|
2024
Q1 | $4.5M | Buy |
56,459
+172
| +0.3% | +$13.1K | 0.17% | 133 |
|
|
2023
Q4 | $4.44M | Buy |
56,287
+829
| +1% | +$59K | 0.18% | 129 |
|
|
2023
Q3 | $3.87M | Sell |
55,458
-3,406
| -6% | -$241K | 0.19% | 128 |
|
|
2023
Q2 | $4.07M | Buy |
58,864
+1,808
| +3% | +$129K | 0.19% | 129 |
|
|
2023
Q1 | $4.24M | Buy |
57,056
+23,336
| +69% | +$1.96M | 0.22% | 120 |
|
|
2022
Q4 | $3.14M | Buy |
33,720
+3,976
| +13% | +$384K | 0.17% | 148 |
|
|
2022
Q3 | $2.84M | Buy |
29,744
+1,167
| +4% | +$116K | 0.17% | 138 |
|
|
2022
Q2 | $2.65M | Buy |
28,577
+129
| +0.5% | +$12.6K | 0.15% | 149 |
|
|
2022
Q1 | $2.88M | Buy |
28,448
+1,094
| +4% | +$115K | 0.14% | 161 |
|
|
2021
Q4 | $2.82M | Buy |
27,354
+2,168
| +9% | +$200K | 0.14% | 168 |
|
|
2021
Q3 | $2.14M | Buy |
25,186
+3,932
| +19% | +$329K | 0.09% | 148 |
|
|
2021
Q2 | $1.77M | Sell |
21,254
-4,823
| -18% | -$395K | 0.1% | 187 |
|
|
2021
Q1 | $1.96M | Buy |
26,077
+5,442
| +26% | +$396K | 0.12% | 170 |
|
|
2020
Q4 | $1.41M | Sell |
20,635
-23,843
| -54% | -$1.55M | 0.1% | 173 |
|
|
2020
Q3 | $2.6M | Buy |
44,478
+23,663
| +114% | +$1.47M | 0.14% | 156 |
|
|
2020
Q2 | $1.35M | Buy |
20,815
+15,303
| +278% | +$964K | 0.12% | 157 |
|
|
2020
Q1 | $327K | Sell |
5,512
-356
| -6% | -$23.8K | 0.06% | 181 |
|
|
2019
Q4 | $436K | Buy |
+5,868
| New | +$412K | 0.08% | 182 |
|
|
2019
Q3 | – | Sell |
-4,834
| Closed | -$263K | – | 247 |
|
|
2019
Q2 | $263K | Sell |
4,834
-160
| -3% | -$8.62K | 0.06% | 190 |
|
|
2019
Q1 | $269K | Buy |
4,994
+658
| +15% | +$40.6K | 0.06% | 188 |
|
|
2018
Q4 | $284K | Buy |
+4,336
| New | +$324K | 0.08% | 171 |
|
|
2018
Q1 | – | Sell |
-35,091
| Closed | -$2.54M | – | 174 |
|
|
2017
Q4 | $2.54M | Sell |
35,091
-8,056
| -19% | -$586K | 0.77% | 46 |
|
|
2017
Q3 | $3.51M | Buy |
43,147
+11,436
| +36% | +$905K | 1.16% | 30 |
|
|
2017
Q2 | $2.55M | Buy |
31,711
+1,406
| +5% | +$111K | 1.04% | 39 |
|
|
2017
Q1 | $2.36M | Buy |
30,305
+3,399
| +13% | +$271K | 1.02% | 37 |
|
|
2016
Q4 | $2.12M | Sell |
26,906
-1,708
| -6% | -$138K | 0.9% | 42 |
|
|
2016
Q3 | $2.41M | Buy |
28,614
+4,233
| +17% | +$400K | 1.07% | 38 |
|
|
2016
Q2 | $2.33M | Buy |
24,381
+5,083
| +26% | +$507K | 1.05% | 39 |
|
|
2016
Q1 | $2M | Buy |
19,298
+1,793
| +10% | +$174K | 0.94% | 49 |
|
|
2015
Q4 | $1.66M | Buy |
17,505
+577
| +3% | +$56.5K | 0.83% | 48 |
|
|
2015
Q3 | $1.63M | Buy |
16,928
+2,906
| +21% | +$306K | 0.8% | 49 |
|
|
2015
Q2 | $1.54M | Buy |
+14,022
| New | +$1.43M | 0.98% | 36 |
|
Other funds holding CVS
Exencial Wealth Advisors's CVS Position: Q1 2026 in Review
Exencial Wealth Advisors reduced its CVS Health (CVS) stake by 7.8% in Q1 2026, selling an estimated $247K and leaving 38,212 shares worth $2.74M. The position accounts for 0.09% of the portfolio, ranked #195.
Exencial Wealth Advisors first reported a position in CVS in Q2 2015 and has held it in 40 quarters since. The position peaked at $4.5M in Q1 2024. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Exencial Wealth Advisors held 38,212 shares of CVS Health worth $2.74M as of Q1 2026.
- Exencial Wealth Advisors sold 3,212 CVS Health shares in Q1 2026, an estimated $247K.
- CVS Health made up 0.09% of Exencial Wealth Advisors's portfolio in Q1 2026, its #195 holding.
- Exencial Wealth Advisors first reported a position in CVS Health in Q2 2015 and has held it in 40 quarters since.
- Exencial Wealth Advisors's CVS Health position peaked at $4.5M in Q1 2024.
- 1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.